Please use this identifier to cite or link to this item:
https://scholarbank.nus.edu.sg/handle/10635/53639
Title: | Induction of Angiogenesis in Microfluidics by using Prolyl Hydroxylase Inhibitor and Sphingosine I-Phosphate | Authors: | LIM SEI HIEN | Keywords: | Ciclopirox olamine (CPX), fibroblasts, S1P1, cellular crosstalk, MCP-1, VEGF | Issue Date: | 15-Aug-2013 | Citation: | LIM SEI HIEN (2013-08-15). Induction of Angiogenesis in Microfluidics by using Prolyl Hydroxylase Inhibitor and Sphingosine I-Phosphate. ScholarBank@NUS Repository. | Abstract: | Prolyl hydroxylase inhibitors (PHis) and sphigosine 1-phosphate (S1P) are shown to induce capillary sprouting in a co-culture microfluidic platform. Combining both factors further enhances the formation of complex tubular networks with lumina. The pro-angiogenic effects are only observed in co-culture with fibroblasts and are explained by the generation of mutually stimulating factors between endothelia (EC) and fibroblasts. S1P induced migration has been shown to be S1P receptor 1 (S1P1) dependent. The downregulation of either VEGF or S1P1 attenuates capillary sprouting and changes the sprouting morphologies. MCP-1 is mainly secreted by fibroblasts, but only in the presence of ECs or EC-conditioned medium, creating an angiogenic effect on sprouting. Blocking antibodies against MCP-1 inhibit the sprouting response. These observations not only confirm the importance of EC-fibroblast crosstalk in angiogenesis but also suggest that the combination of PHi and S1P enhances this synergy and thus might be of therapeutic value for tissue regeneration. | URI: | http://scholarbank.nus.edu.sg/handle/10635/53639 |
Appears in Collections: | Ph.D Theses (Open) |
Show full item record
Files in This Item:
File | Description | Size | Format | Access Settings | Version | |
---|---|---|---|---|---|---|
LimSH.pdf | 6.02 MB | Adobe PDF | OPEN | None | View/Download |
Google ScholarTM
Check
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.